| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |